drug

RIFADIN

Marketedupdated 3mo ago

by Sanofi-Aventis US LLC

Approved

community read0 votes

🐶 often sniffed alongside

top 8

all catalysts(100)

approval · 100

May 21, 1971

approval

55y ago

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN (RIFAMPIN) — FDA approval

RIFADIN

→

view all 100 catalysts →

Trials studying RIFADIN

phase1A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)not yet recruitingn=14
phase1A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participantsterminatedn=22
phase1The Study on Effects of CYP3A and P-glycoprotein Inhibitor Itraconazole and CYP Enzyme Inducer Rifampin of HMPL-453 Tartrate Tabletscompletedn=40
phase2Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TBcompletedn=122
phase1Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participantsnot yet recruitingn=28
phase1This is an Open-label, Non-randomized Study to Assess the Pharmacokinetics (PK) of VCT220 in Healthy Volunteers When Administered With Rifampin or Itraconazolecompletedn=32
phase1An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participantsrecruitingn=60
phase1Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccinescompletedn=20

more trials →

News(0)

no news has mentioned this drug yet

Data sources

openFDA · ClinicalTrials.gov

last refreshed 38m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

RIFADIN

🐶 often sniffed alongside

all catalysts(100)

Trials studying RIFADIN

News(0)

Report a data issue

comments(0)

RIFADIN

🐶 often sniffed alongside

all catalysts(100)

Trials studying RIFADIN

News(0)

Report a data issue

comments(0)